Related Experiment Video
Updated: May 5, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Chlamydia pneumoniae infection induces vascular smooth muscle cell migration via Rac1 activation
Junxia Zhang1, Haiwei Wang1, Lijun Zhang1
1Department of Pathophysiology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, PR China.
Abstract:
Chlamydia pneumoniae infection has been shown to be associated with the development of atherosclerosis by promoting the migration of vascular smooth muscle cells (VSMCs). However, how C. pneumoniae infection induces VSMC migration is not fully understood. A primary role of Ras-related C3 botulinum toxin substrate 1 (Rac1) is to generate a protrusive force at the leading edge that contributes to cell migration. Whether Rac1 activation plays a role in C. pneumoniae infection-induced VSMC migration is not well defined. In the present study, we therefore examined Rac1 activation in C. pneumoniae-infected rat primary VSMCs and the role of Rac1 activation in C. pneumoniae infection-induced VSMC migration. Glutathione S-transferase pull-down assay results showed that Rac1 was activated in C. pneumoniae-infected rat primary VSMCs. A Rac1 inhibitor, NSC23766 (50 µM,) suppressed Rac1 activation stimulated by C. pneumoniae infection, and thereby inhibited C. pneumoniae infection-induced VSMC migration. In addition, C. pneumoniae infection-induced Rac1 activation in the VSMCs was blocked by LY294002 (25 µM), an inhibitor of phosphatidylinositol 3-kinase (PI3K). Taken together, these data suggest that C. pneumoniae infection promotes VSMC migration, possibly through activating Rac1 via PI3K.
Insights
Chlamydia pneumoniae infection promotes vascular smooth muscle cell migration by activating Ras-related C3 botulinum toxin substrate 1 (Rac1) via phosphatidylinositol 3-kinase (PI3K). Inhibiting Rac1 blocks this infection-induced cell migration, suggesting a key pathway in atherosclerosis development.
Area of Science:
- Cardiovascular Biology
- Infectious Disease Immunology
- Cellular Signaling
Background:
- Chlamydia pneumoniae infection is linked to atherosclerosis development.
- Vascular smooth muscle cell (VSMC) migration is a key process in atherosclerosis.
- The precise mechanisms by which C. pneumoniae induces VSMC migration remain unclear.
Purpose of the Study:
- To investigate the role of Ras-related C3 botulinum toxin substrate 1 (Rac1) activation in C. pneumoniae infection-induced VSMC migration.
- To explore the upstream signaling pathways involved in Rac1 activation.
Main Methods:
- Utilized rat primary VSMCs infected with C. pneumoniae.
- Employed glutathione S-transferase pull-down assays to assess Rac1 activation.
- Administered Rac1 inhibitor (NSC23766) and PI3K inhibitor (LY294002) to evaluate their effects.
Main Results:
- Rac1 activation was observed in C. pneumoniae-infected VSMCs.
- The Rac1 inhibitor NSC23766 significantly suppressed C. pneumoniae-induced VSMC migration.
- LY294002, a PI3K inhibitor, blocked C. pneumoniae-induced Rac1 activation.
Conclusions:
- C. pneumoniae infection promotes VSMC migration.
- Rac1 activation, potentially mediated by PI3K signaling, is a crucial mechanism in this process.
- Targeting the PI3K-Rac1 pathway may offer therapeutic strategies for C. pneumoniae-associated atherosclerosis.
More Related Videos
10:43Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
Published on: May 19, 2016
08:28Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
Related Concept Videos
Cell Polarization by Rho Proteins
Bacterial Phylum Chlamydiae
Intracellular Movement of Viruses and Bacteria
Cytoskeletal Coordination in Cell Migration
Atherosclerosis I: Introduction
Cell Migration